A61K 36/09
Lichens
A61K36/09 (Lichens) appears on 27 US grants and 45 published applications in this corpus.
Search patents in A61K- Granted patents
- 27
- Published applications
- 45
- Assignees
- 28
- Inventors
- 103
- Latest grant
- 16 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 3 |
| 2004 | 1 | 0 |
| 2005 | 0 | 3 |
| 2006 | 2 | 0 |
| 2007 | 0 | 2 |
| 2008 | 0 | 2 |
| 2009 | 0 | 2 |
| 2010 | 1 | 0 |
| 2011 | 2 | 1 |
| 2012 | 0 | 2 |
| 2013 | 2 | 3 |
| 2014 | 2 | 2 |
| 2015 | 1 | 1 |
| 2016 | 2 | 3 |
| 2017 | 1 | 1 |
| 2018 | 1 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 2 | 8 |
| 2022 | 2 | 4 |
| 2023 | 1 | 1 |
| 2024 | 1 | 3 |
| 2025 | 2 | 3 |
| 2026 | 2 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Controlled release concentrate and suspensions including the same16 Jun 2026US 12,653,782 B2Nulixir Inc.
- Composition for the treatment of skin and mucous membrane diseases26 May 2026US 12,636,330 B2Neilos S.R.L.
- Controlled release core-shell particles and suspensions including the same2 Dec 2025US 12,485,091 B2Nulixir Inc.
- Particles for administration of active ingredients and methods of making the same8 Jul 2025US 12,350,367 B2Nulixir Inc.
- Water soluble compositions and methods of making the same23 Apr 2024US 11,964,049 B2Nulixir Inc.
- Parmelia tinctorum polysaccharide xep-70, method of preparation, and use thereof4 Sep 2025US 2025/0276003 A1Northwest Institute of Plateau Biology, Chinese Academy of Sciences
- Natural matrix mixture for the treatment of bone fragility17 Jul 2025US 2025/0228900 A1Bios-Therapy, Physiological Systems for Health S.p.A.
- Mushroom Spore, Cannabinoid, and Specified Compositions27 Feb 2025US 2025/0064874 A1
- Water soluble compositions and methods of making the same21 Nov 2024US 2024/0382421 A1Nulixir Inc.
- Methods of using compositions comprising an iceland moss extract13 Jun 2024US 2024/0189377 A1Johnson & Johnson Consumer Inc.
Most cited
By later US patents
- Immunomodulating compositions and methods of use28US 8,580,253 B2Massachusetts Institute of Technology · 2013
- Immunomodulating compositions and methods of use thereof26US 9,457,047 B2Massachusetts Institute of Technology · 2016
- Controlled release core-shell particles and suspensions including the same6US 10,945,953 B1Nulixir Inc. · 2021
- Preparation for oral administration3US 7,135,198 B2Bogar AG · 2006
- Anti-inflammatory dissolvable film3US 8,021,696 B2Izun Pharmaceuticals Corp. · 2011